We are live on
!
Find out more
II
IFM Investors Portfolio holdings
AUM
$15.1B
1-Year Est. Return
40.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.83%
1 Year Est. Return
+40.57%
3 Year Est. Return
+130.57%
5 Year Est. Return
+172.93%
10 Year Est. Return
–
AUM
$2.83B
AUM Growth
+$129M
(+4.8%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
22.2%
Holding
627
New
19
Increased
62
Reduced
525
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$3.7M |
| 2 |
Blackstone
BX
|
+$3.17M |
| 3 |
Truist Financial
TFC
|
+$3.01M |
| 4 |
RingCentral
RNG
|
+$1.16M |
| 5 |
Insulet
PODD
|
+$972K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$7.53M |
| 2 |
Apple
AAPL
|
+$6.48M |
| 3 |
Microsoft
MSFT
|
+$4.04M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$3.33M |
| 5 |
Amazon
AMZN
|
+$2.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.88% |
| 2 | Financials | 15.63% |
| 3 | Healthcare | 13.73% |
| 4 | Communication Services | 10.53% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW
101
Charles Schwab
SCHW
$188B
| $5.87M | 0.21% |
123,329
-6,601
| -5% | -$291K |
|
102
Biogen
BIIB
$30.5B
| $5.83M | 0.21% |
19,663
-1,521
| -7% | -$422K |
|
103
SLB Ltd
SLB
$74.1B
| $5.82M | 0.21% |
144,695
-6,708
| -4% | -$240K |
|
104
Applied Materials
AMAT
$424B
| $5.81M | 0.21% |
95,243
-5,778
| -6% | -$325K |
|
105
Prologis
PLD
$131B
| $5.81M | 0.21% |
65,203
-2,752
| -4% | -$244K |
|
106
Vertex Pharmaceuticals
VRTX
$123B
| $5.78M | 0.2% |
26,418
-1,178
| -4% | -$238K |
|
107
Altria Group
MO
$114B
| $5.78M | 0.2% |
115,769
| – | – |
|
108
Colgate-Palmolive
CL
$74.4B
| $5.78M | 0.2% |
83,911
-3,863
| -4% | -$263K |
|
109
Tesla
TSLA
$1.27T
| $5.78M | 0.2% |
207,090
-6,390
| -3% | -$139K |
|
110
CSX Corp
CSX
$94.7B
| $5.73M | 0.2% |
237,726
-13,980
| -6% | -$331K |
|
111
Norfolk Southern
NSC
$76.8B
| $5.72M | 0.2% |
29,459
+471
| +2% | +$88.3K |
|
112
Intercontinental Exchange
ICE
$84.1B
| $5.63M | 0.2% |
60,784
+225
| +0.4% | +$20.9K |
|
113
Global Payments
GPN
$23.9B
| $5.58M | 0.2% |
30,569
-1,552
| -5% | -$266K |
|
114
Northrop Grumman
NOC
$79.2B
| $5.42M | 0.19% |
15,748
-1,548
| -9% | -$544K |
|
115
Deere & Co
DE
$165B
| $5.36M | 0.19% |
30,927
-1,489
| -5% | -$256K |
|
116
ServiceNow
NOW
$121B
| $5.34M | 0.19% |
94,595
-3,960
| -4% | -$209K |
|
117
Air Products & Chemicals
APD
$65.7B
| $5.28M | 0.19% |
22,485
-970
| -4% | -$219K |
|
118
Phillips 66
PSX
$81.2B
| $5.19M | 0.18% |
46,617
-2,134
| -4% | -$240K |
|
119
Humana
HUM
$43.7B
| $5.17M | 0.18% |
14,108
-684
| -5% | -$217K |
|
120
Ecolab
ECL
$80.3B
| $5.12M | 0.18% |
26,518
-1,195
| -4% | -$227K |
|
121
Equinix
EQIX
$104B
| $5.08M | 0.18% |
8,697
-387
| -4% | -$217K |
|
122
EOG Resources
EOG
$71.5B
| $5.05M | 0.18% |
60,262
-2,645
| -4% | -$194K |
|
123
Illumina
ILMN
$30.2B
| $5.02M | 0.18% |
15,564
-747
| -5% | -$226K |
|
124
Capital One
COF
$136B
| $5M | 0.18% |
48,632
-2,284
| -4% | -$220K |
|
125
DuPont de Nemours
DD
$19.9B
| $4.98M | 0.18% |
61,742
-3,316
| -5% | -$275K |
|
Similar funds
IA
AT
UM
FCAS
RFC
GF
IFM Investors's Q4 2019 Portfolio in Review
As of Q4 2019, IFM Investors held 627 positions worth $2.83B, up 4.8% from $2.71B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
IFM Investors withdrew a net $101M in Q4 2019, closing 17 positions and reducing 525 holdings. Its most notable exit was Celgene Corp, an estimated $7.53M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, IFM Investors opened a new position in Blackstone worth $3.42M.
- IFM Investors's largest Q4 2019 buy was Blackstone: 61,161 shares worth $3.42M.
- IFM Investors added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.7M increase.
- IFM Investors's biggest Q4 2019 reduction was Apple, cutting an estimated $6.48M.
- IFM Investors fully exited Celgene Corp in Q4 2019, selling an estimated $7.53M.
- IFM Investors's ten largest holdings make up 22% of its $2.83B portfolio in Q4 2019.
- IFM Investors opened 19 new positions and closed 17 in Q4 2019.
- IFM Investors's portfolio value rose 4.8% quarter-over-quarter to $2.83B.
Based on IFM Investors's 13F filing for Q4 2019, filed 13 Jan 2020.